Get the Stockscreener App
6.76
8.86%
+0.55
After Hours:
6.50
-0.26
-3.85%
Amneal Pharmaceuticals Inc Stock (AMRX) Forecast
The Amneal Pharmaceuticals Inc (AMRX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $4.3584, representing a -35.53% decrease from the current price of $6.76. The highest analyst price target is $4.7287, and the lowest is $3.988.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month AMRX Price Target
Average 7.063
(+4.48% Upside)
Is Amneal Pharmaceuticals Inc (AMRX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 72.62 | Sell |
| STOCH(9,6) | 86.92 | Sell |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | 0.1473 | Buy |
| ADX(14) | 24.72 | Neutral |
| William %R | -8.1395 | Sell |
| CCI(14) | 154.45 | Buy |
Buy: 2
Sell: 4
Neutral: 1
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
5.967
Buy
|
6.0733
Buy
|
| MA20 |
5.7768
Buy
|
5.9177
Buy
|
| MA50 |
5.7539
Buy
|
5.7685
Buy
|
| MA100 |
5.6548
Buy
|
5.4894
Buy
|
| MA200 |
4.8418
Buy
|
4.7754
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, AMRX could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 4 signaling Sell signals and 1 Neutral signals. This might be a good time to open fresh positions on AMRX, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 72.62 indicates that AMRX is overbought. This suggests that AMRX price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
- STOCH (Stochastic Oscillator): The STOCH value of 86.92 indicates that AMRX is oversold. This means that AMRX price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that AMRX is oversold. This suggests that AMRX price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 24.72 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 154.45 indicates that AMRX is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term AMRX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Amneal Pharmaceuticals Inc financial reports and earnings history, Amneal Pharmaceuticals Inc (AMRX) stock could reach $20.22 by 2030, $57.04 by 2040 and $72.64 by 2050. See the projected annual prices until 2050 of the Amneal Pharmaceuticals Inc stock below:
- Amneal Pharmaceuticals Inc (AMRX) is expected to reach an average price of $26.99 in 2035, with a high prediction of $27.05 and a low estimate of $25.41. This indicates an $299.28% rise from the last recorded price of $6.76.
- Amneal Pharmaceuticals Inc (AMRX) stock is projected to chart a bullish course in 2040, with an average price target of $56.65, representing an $737.99% surge from its current level. The forecast ranges from a conservative $54.62 to a sky-high $57.04.
- Our analysts predict Amneal Pharmaceuticals Inc (AMRX) to jump 887.07% by 2045, soaring from $63.92 to an average price of $66.73, potentially reaching $66.77. While $63.92 is the low estimate, the potential upside is significant.
- Amneal Pharmaceuticals Inc (AMRX) stock is expected to climb by 2050, reaching an average of $72.31, a $969.64% jump from its current level. However, a wide range of estimates exists, with high and low targets of $72.64 and $70.65, respectively, highlighting the market's uncertainty.
Amneal Pharmaceuticals Inc Stock (AMRX) Year by Year Forecast
Amneal Pharmaceuticals Inc Stock (AMRX) Price Forecast for 2024
Our forecast for AMRX stock price in 2024 now indicates an average price target of $5.9754 with a high forecast of $8.0598 and a low forecast of $3.8909. The average prediction reflects an decrease of -11.61% from the last recorded price of $6.76.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $4.6887 | $3.988 | $4.7287 | -30.64% |
| July, 2024 | $5.2336 | $4.5407 | $5.3436 | -22.58% |
| August, 2024 | $5.8814 | $5.1905 | $5.9914 | -13.00% |
| September, 2024 | $6.4793 | $5.3454 | $6.7193 | -4.15% |
| October, 2024 | $6.9741 | $6.1262 | $7.9571 | +3.17% |
| November, 2024 | $7.122 | $6.9511 | $7.71 | +5.35% |
| December, 2024 | $7.6498 | $7.1189 | $8.0598 | +13.16% |
Amneal Pharmaceuticals Inc Stock (AMRX) Price Forecast for 2025
Amneal Pharmaceuticals Inc Stock (AMRX) is expected to reach an average price of $8.5907 in 2025, with a high prediction of $10.67 and a low estimate of $6.5065. This indicates an +27.08% rise from the last recorded price of $6.76.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $7.8846 | $6.9007 | $7.9446 | +16.64% |
| February, 2025 | $8.0125 | $7.5816 | $8.3286 | +18.53% |
| March, 2025 | $9.5704 | $7.9795 | $9.6104 | +41.57% |
| April, 2025 | $9.4352 | $9.1082 | $10.14 | +39.57% |
| May, 2025 | $9.953 | $9.2341 | $10.14 | +47.23% |
| June, 2025 | $9.5509 | $9.1439 | $10.28 | +41.29% |
| July, 2025 | $9.8157 | $9.4379 | $10.67 | +45.20% |
| August, 2025 | $10.06 | $9.5296 | $10.59 | +48.84% |
| September, 2025 | $6.6918 | $6.5065 | $9.035 | -1.01% |
| October, 2025 | $7.4914 | $6.6658 | $7.5514 | +10.82% |
| November, 2025 | $8.1271 | $7.3654 | $8.2371 | +20.22% |
| December, 2025 | $9.1568 | $8.1111 | $9.1818 | +35.46% |
Amneal Pharmaceuticals Inc Stock (AMRX) Price Forecast for 2026
The predicted value for Amneal Pharmaceuticals Inc (AMRX) in 2026 is set at an average of $11.70. Estimates vary from a peak of $15.00 to a trough of $8.4007, indicating an +73.06% surge from the present price of $6.76.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $9.4325 | $8.4007 | $9.8286 | +39.53% |
| February, 2026 | $10.22 | $9.4704 | $11.17 | +51.16% |
| March, 2026 | $10.47 | $10.22 | $11.03 | +54.94% |
| April, 2026 | $10.81 | $10.50 | $11.52 | +59.96% |
| May, 2026 | $11.48 | $10.44 | $11.54 | +69.81% |
| June, 2026 | $11.71 | $11.20 | $11.98 | +73.30% |
| July, 2026 | $13.74 | $11.71 | $13.97 | +103.32% |
| August, 2026 | $13.38 | $13.03 | $13.84 | +97.93% |
| September, 2026 | $13.96 | $13.23 | $14.19 | +106.51% |
| October, 2026 | $13.88 | $13.28 | $14.42 | +105.26% |
| November, 2026 | $14.11 | $13.91 | $14.89 | +108.75% |
| December, 2026 | $11.26 | $10.97 | $15.00 | +66.57% |
Amneal Pharmaceuticals Inc Stock (AMRX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Amneal Pharmaceuticals Inc (AMRX) is $13.46, with a high forecast of $17.81 and a low forecast of $9.1035. This indicates an +99.08% increase from the last price of $6.76.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $9.4336 | $9.1035 | $9.5036 | +39.55% |
| February, 2027 | $10.28 | $9.4445 | $10.34 | +52.03% |
| March, 2027 | $11.31 | $10.18 | $11.36 | +67.33% |
| April, 2027 | $12.19 | $11.22 | $12.21 | +80.25% |
| May, 2027 | $12.57 | $11.46 | $12.94 | +85.93% |
| June, 2027 | $13.72 | $12.64 | $14.39 | +103.01% |
| July, 2027 | $14.25 | $13.70 | $14.36 | +110.75% |
| August, 2027 | $14.30 | $14.11 | $14.98 | +111.54% |
| September, 2027 | $15.08 | $13.98 | $15.43 | +123.15% |
| October, 2027 | $15.85 | $15.10 | $15.88 | +134.44% |
| November, 2027 | $17.58 | $15.78 | $17.81 | +160.09% |
| December, 2027 | $17.27 | $16.94 | $17.72 | +155.42% |
Amneal Pharmaceuticals Inc Stock (AMRX) Price Forecast for 2028
In 2028, Amneal Pharmaceuticals Inc (AMRX) is projected to reach an average price of $15.55, with a high projection of $19.40 and a low estimate of $11.70. This indicates an +130.04% rise from the last price of $6.76.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $18.04 | $17.23 | $18.24 | +166.86% |
| February, 2028 | $18.06 | $17.41 | $18.55 | +167.21% |
| March, 2028 | $18.39 | $18.12 | $19.10 | +172.01% |
| April, 2028 | $13.83 | $13.54 | $19.40 | +104.59% |
| May, 2028 | $12.18 | $11.70 | $12.30 | +80.17% |
| June, 2028 | $13.17 | $12.33 | $13.28 | +94.83% |
| July, 2028 | $14.23 | $13.25 | $14.28 | +110.53% |
| August, 2028 | $15.35 | $14.17 | $15.41 | +127.09% |
| September, 2028 | $15.85 | $15.28 | $16.05 | +134.51% |
| October, 2028 | $16.99 | $15.85 | $17.61 | +151.39% |
| November, 2028 | $17.81 | $17.05 | $18.14 | +163.51% |
| December, 2028 | $17.52 | $17.49 | $18.44 | +159.25% |
Amneal Pharmaceuticals Inc Stock (AMRX) Price Forecast for 2029
The 2029 price forecast for Amneal Pharmaceuticals Inc Stock (AMRX) is $19.05 on average, with a high prediction of $23.80 and a low estimate of $14.30. This represents an +181.82% increase from the previous price of $6.76.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $19.12 | $17.52 | $19.27 | +182.90% |
| February, 2029 | $20.09 | $18.97 | $20.27 | +197.13% |
| March, 2029 | $21.45 | $19.59 | $21.65 | +217.27% |
| April, 2029 | $21.24 | $20.86 | $21.69 | +214.18% |
| May, 2029 | $21.95 | $21.23 | $22.35 | +224.67% |
| June, 2029 | $22.93 | $21.55 | $23.32 | +239.19% |
| July, 2029 | $22.71 | $22.60 | $23.28 | +235.96% |
| August, 2029 | $14.41 | $14.30 | $23.80 | +113.24% |
| September, 2029 | $14.88 | $14.40 | $15.00 | +120.18% |
| October, 2029 | $16.51 | $15.06 | $16.52 | +144.20% |
| November, 2029 | $17.18 | $16.48 | $17.36 | +154.11% |
| December, 2029 | $18.41 | $17.34 | $18.47 | +172.29% |
Amneal Pharmaceuticals Inc Stock (AMRX) Price Forecast for 2030
Amneal Pharmaceuticals Inc Stock (AMRX) is expected to reach an average price of $22.55 in 2030, with a high forecast of $28.21 and a low forecast of $16.89. This signifies an +233.60% surge from the last price of $6.76.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $20.06 | $18.36 | $20.22 | +196.76% |
| February, 2030 | $20.58 | $19.80 | $20.83 | +204.44% |
| March, 2030 | $21.22 | $20.40 | $21.55 | +213.90% |
| April, 2030 | $21.04 | $21.01 | $21.90 | +211.22% |
| May, 2030 | $22.77 | $21.06 | $22.92 | +236.88% |
| June, 2030 | $23.84 | $22.67 | $24.03 | +252.69% |
| July, 2030 | $24.86 | $23.38 | $25.49 | +267.70% |
| August, 2030 | $25.52 | $24.78 | $25.67 | +277.45% |
| September, 2030 | $26.05 | $25.42 | $26.45 | +285.43% |
| October, 2030 | $27.27 | $25.68 | $27.53 | +303.39% |
| November, 2030 | $27.62 | $26.90 | $27.86 | +308.55% |
| December, 2030 | $17.01 | $16.89 | $28.21 | +151.65% |
0.45%
2.19%
Cap:
|
Volume (24h):